Literature DB >> 1624174

Oesophageal candidiasis after omeprazole therapy.

A J Larner1, R Lendrum.   

Abstract

Oesophageal candidiasis was diagnosed incidentally at endoscopy in two patients receiving omeprazole therapy. There were no other predisposing factors for the development of candidiasis. The infection was resolved rapidly by anti-candidal therapy and by stopping omeprazole. These findings suggest that gastric acid secretion and physiological reflux of acid into the oesophagus may play a protective role in preventing candida infection.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1624174      PMCID： PMC1379351          DOI： 10.1136/gut.33.6.860

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


  13 in total

Review 1.  Omeprazole.

Authors:  P N Maton
Journal:  N Engl J Med       Date:  1991-04-04       Impact factor: 91.245

2.  Acid reduction and recurrent enteritis.

Authors:  D L Wingate
Journal:  Lancet       Date:  1990-01-27       Impact factor: 79.321

3.  Potent acid reduction and risk of enteric infection.

Authors:  A Littman
Journal:  Lancet       Date:  1990-01-27       Impact factor: 79.321

4.  Invasive candidiasis following cimetidine therapy.

Authors:  R Kochhar; P Talwar; S Singh; S K Mehta
Journal:  Am J Gastroenterol       Date:  1988-01       Impact factor: 10.864

5.  Double blind comparison of omeprazole (40 mg od) versus cimetidine (400 mg qd) in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24 h pH monitoring.

Authors:  T C Dehn; H A Shepherd; D Colin-Jones; M G Kettlewell; N J Carroll
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

6.  Systemic candidiasis complicating acute hepatic failure in patients treated with cimetidine.

Authors:  D R Triger; J R Goepel; D N Slater; J C Underwood
Journal:  Lancet       Date:  1981-10-17       Impact factor: 79.321

7.  Candida peritonitis and cimetidine.

Authors:  F R Stark; N Ninos; J Hutton; R Katz; M Butler
Journal:  Lancet       Date:  1978-09-30       Impact factor: 79.321

8.  Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole.

Authors:  B K Sharma; I A Santana; E C Wood; R P Walt; M Pereira; P Noone; P L Smith; C L Walters; R E Pounder
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-22

9.  The clinical safety of omeprazole.

Authors:  L Sölvell
Journal:  Scand J Gastroenterol Suppl       Date:  1989

10.  Bacteriology of the stomach immediately following vagotomy: the growth of Candida albicans.

Authors:  J R Brooks; H F Smith; F B Pease
Journal:  Ann Surg       Date:  1974-06       Impact factor: 12.969
View more
  9 in total

1.  Acid suppression therapy as a risk factor for Candida esophagitis.

Authors:  Kyung-Yup Kim; Jae Young Jang; Jung-Wook Kim; Jae-Jun Shim; Chang Kyun Lee; Seok Ho Dong; Hyo Jong Kim; Byung-Ho Kim; Young Woon Chang
Journal:  Dig Dis Sci       Date:  2013-01-10       Impact factor: 3.199

Review 2.  Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.

Authors:  Leon Fisher; Alexander Fisher
Journal:  Clin Drug Investig       Date:  2017-07       Impact factor: 2.859

3.  Oesophageal acid clearance.

Authors:  A J Larner
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

4.  Risk factors for Salmonella infection. Loss of gastric acid linked to candidiasis.

Authors:  A J Larner
Journal:  BMJ       Date:  1994-02-26

Review 5.  A comparative overview of the adverse effects of antiulcer drugs.

Authors:  D W Piper
Journal:  Drug Saf       Date:  1995-02       Impact factor: 5.606

Review 6.  Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders.

Authors:  M I Wilde; D McTavish
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

7.  Risk factors for the development of esophageal candidiasis among patients in community hospital.

Authors:  Hideyuki Ogiso; Seiji Adachi; Masatoshi Mabuchi; Yohei Horibe; Tomohiko Ohno; Yusuke Suzuki; Osamu Yamauchi; Takao Kojima; Eri Takada; Midori Iwama; Koshiro Saito; Takuji Iwashita; Takashi Ibuka; Ichiro Yasuda; Masahito Shimizu
Journal:  Sci Rep       Date:  2021-10-19       Impact factor: 4.379

Review 8.  Oesophageal candidiasis in elderly patients: risk factors, prevention and management.

Authors:  Namal Weerasuriya; Jeremy Snape
Journal:  Drugs Aging       Date:  2008       Impact factor: 4.271

Review 9.  The Phylogeny and Biological Function of Gastric Juice-Microbiological Consequences of Removing Gastric Acid.

Authors:  Tom C Martinsen; Reidar Fossmark; Helge L Waldum
Journal:  Int J Mol Sci       Date:  2019-11-29       Impact factor: 5.923
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.